Insider Transactions in Q1 2023 at Sema4 Holdings Corp. (SMFR)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
31,876
-29.05%
|
$0
$0.36 P/Share
|
|
Mar 10
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
SELL
Open market or private sale
|
Direct |
35,200
-16.48%
|
$0
$0.36 P/Share
|
|
Mar 10
2023
|
Katherine Stueland Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
92,644
-23.09%
|
$0
$0.36 P/Share
|
|
Mar 10
2023
|
Karen Ann White Chief People Officer |
SELL
Open market or private sale
|
Direct |
32,787
-38.59%
|
$0
$0.36 P/Share
|
|
Mar 09
2023
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
81,250
+42.54%
|
-
|
|
Mar 09
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
93,750
+30.5%
|
-
|
|
Mar 09
2023
|
Katherine Stueland Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
216,033
+35.0%
|
-
|
|
Mar 09
2023
|
Karen Ann White Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+42.38%
|
-
|
|
Mar 02
2023
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,397
-26.74%
|
$0
$0.45 P/Share
|
|
Mar 01
2023
|
Kevin Feeley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,674
+37.84%
|
-
|
|
Jan 31
2023
|
School Of Medicine At Mount Sinai Icahn > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
28,571,428
+18.83%
|
$0
$0.35 P/Share
|
|
Jan 31
2023
|
Keith A. Meister |
BUY
Grant, award, or other acquisition
|
Indirect |
77,663,376
+44.26%
|
$0
$0.35 P/Share
|
|
Jan 31
2023
|
Eli Casdin |
BUY
Open market or private purchase
|
Indirect |
85,714,285
+47.42%
|
$0
$0.35 P/Share
|
|
Jan 27
2023
|
Joshua Ruch |
BUY
Grant, award, or other acquisition
|
Indirect |
4,285,714
+40.07%
|
$0
$0.35 P/Share
|
|
Jan 26
2023
|
Opko Health, Inc. |
BUY
Open market or private purchase
|
Direct |
14,285,714
+13.16%
|
$0
$0.35 P/Share
|
|
Jan 26
2023
|
Karen Ann White Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,241
-9.98%
|
$0
$0.36 P/Share
|
|
Jan 25
2023
|
Karen Ann White Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,503
+16.71%
|
-
|
|
Jan 20
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
SELL
Open market or private sale
|
Direct |
6,292
-5.25%
|
$0
$0.38 P/Share
|
|
Jan 19
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
18,014
+13.07%
|
-
|
|
Jan 04
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
SELL
Open market or private sale
|
Direct |
3,170
-3.02%
|
$0
$0.26 P/Share
|
|
Jan 04
2023
|
Karen Ann White Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,630
-8.33%
|
$0
$0.26 P/Share
|
|
Jan 01
2023
|
Karen Ann White Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,276
+14.34%
|
-
|
|
Jan 01
2023
|
Kareem Saad CHIEF TRANSFORMATION OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,005
+7.9%
|
-
|